LivaNova PLC - Asset Resilience Ratio
LivaNova PLC (LIVN) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of LivaNova PLC to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1998–2022)
This chart shows how LivaNova PLC's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of LivaNova PLC.
Liquid Assets Composition Over Time
This chart breaks down LivaNova PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore LIVN long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $42.00K | 0.0% |
| Total Liquid Assets | $42.00K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: LivaNova PLC maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
LivaNova PLC Industry Peers by Asset Resilience Ratio
Compare LivaNova PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 12.10% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for LivaNova PLC (1998–2022)
The table below shows the annual Asset Resilience Ratio data for LivaNova PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.00% | $-34.00K | $2.29 Billion | 0.00pp |
| 2021-12-31 | 0.00% | $-2.00K | $2.20 Billion | -1.30pp |
| 2020-12-31 | 1.30% | $31.09 Million | $2.40 Billion | +1.19pp |
| 2018-12-31 | 0.10% | $2.65 Million | $2.55 Billion | -0.01pp |
| 2017-12-31 | 0.12% | $2.94 Million | $2.50 Billion | +0.12pp |
| 2016-12-31 | 0.00% | $-8.00K | $2.34 Billion | -0.27pp |
| 2015-12-31 | 0.27% | $7.00 Million | $2.56 Billion | -8.23pp |
| 2014-12-31 | 8.51% | $25.03 Million | $294.19 Million | 0.00pp |
| 2013-12-31 | 8.51% | $25.03 Million | $294.19 Million | +2.79pp |
| 2012-12-31 | 5.72% | $15.10 Million | $264.04 Million | -1.36pp |
| 2011-12-31 | 7.08% | $15.00 Million | $211.91 Million | +6.60pp |
| 2009-12-31 | 0.48% | $1.00 Million | $207.47 Million | -0.20pp |
| 2008-12-31 | 0.68% | $1.00 Million | $146.21 Million | -0.27pp |
| 2007-12-31 | 0.95% | $1.00 Million | $105.19 Million | +0.22pp |
| 2006-12-31 | 0.73% | $1.00 Million | $136.23 Million | +0.08pp |
| 2005-12-31 | 0.66% | $1.00 Million | $152.30 Million | -22.41pp |
| 2004-12-31 | 23.06% | $22.80 Million | $98.86 Million | +22.98pp |
| 2000-12-31 | 0.08% | $57.54K | $67.99 Million | -3.80pp |
| 1999-12-31 | 3.89% | $1.56 Million | $40.00 Million | -44.35pp |
| 1998-12-31 | 48.24% | $19.20 Million | $39.80 Million | -- |
About LivaNova PLC
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessor… Read more